Related Experiment Videos

3-Aminobenzamide induces cytoskeleton rearrangement in M14 melanoma cells

W Malorni1, G Rainaldi, E Straface

  • 1Department of Ultrastructures, Istituto Superiore di Sanità, Roma, Italy.

Insights

3-aminobenzamide (3-ABA) inhibits poly-ADP-ribose-polymerase, impacting melanoma cell growth and causing dendritic protrusions. These effects suggest 3-ABA influences the cytoskeleton and may have differentiating capabilities.

Area of Science:

  • Cell Biology
  • Biochemistry
  • Pharmacology

Background:

  • 3-aminobenzamide (3-ABA) is a poly-ADP-ribose-polymerase inhibitor.
  • Poly-ADP-ribose-polymerase is involved in critical cellular processes, including cell death.
  • The precise mechanism of action for 3-ABA remains incompletely understood.

Purpose of the Study:

  • To investigate the effects of 3-ABA on cultured M14 melanoma cells.
  • To elucidate the mode of action of 3-ABA.
  • To explore the potential role of the cytoskeleton in 3-ABA's effects.

Main Methods:

  • Cultured M14 melanoma cells were treated with 3-ABA.
  • Cell growth and morphology were assessed.
  • Cytoskeletal elements were examined for drug-induced alterations.

Main Results:

  • 3-ABA treatment impaired the growth of M14 melanoma cells.
  • Cells exhibited the formation of extensive, long, dendritic-like protrusions.
  • These morphological changes suggest a specific interaction with cytoskeletal components.

Conclusions:

  • 3-ABA significantly affects melanoma cell morphology and growth.
  • The cytoskeleton appears to be a key target of 3-ABA.
  • 3-ABA may possess differentiating capabilities, potentially mediated through cytoskeletal modulation.

Related Concept Videos